Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00104195 · ClinicalTrials.gov registry record
A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 127
- Enrollment target
NCT00104195: Completed study, sponsored by NYU Langone Health.
NCT00104195 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 127 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00104195 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 127 participants
- Enrollment target
Study Summary
The purpose of this trial is to study how teens with and without an anxiety disorder make decisions. This is a brain imaging study using functional magnetic resonance imaging (fMRI) in adolescents between the ages of 13 and 17.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2004-02 |
| Est. Completion | 2014-04 |
What the finished NCT00104195 record still lists
NCT00104195 is an observational study that tracks outcomes without assigning an intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00104195 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00104195 about?
NCT00104195 is a clinical study titled "A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions". The purpose of this trial is to study how teens with and without an anxiety disorder make decisions. This is a brain imaging study using functional magnetic resonance imaging (fMRI) in adolescents between the ages of 13 and 17.
What is the current status of trial NCT00104195?
This trial is currently completed. The enrollment target is 127 participants. The study started on 2004-02. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT00104195?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03017820 · 127 participants · Phase 1
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- NCT03609580 · 127 participants · Phase 1
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
- NCT06285643 · 127 participants · Phase 2
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- NCT06809400 · 127 participants · Phase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia